Printed on 7/21/2026
For informational purposes only. This is not medical advice.
IQCODE-16 is an informant-based questionnaire that asks how an older adult’s cognition has changed over time relative to prior baseline. Each of 16 items is scored 1 to 5 (much improved to much worse). The mean score (total/16) is used for interpretation, with higher means indicating greater decline.
Formula: Mean IQCODE-16 score = total score / 16 (total range 16-80; mean range 1.0-5.0).
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) requires a reliable informant who has known the patient for at least 10 years and has observed them regularly. The ideal informant is a spouse, adult child, or long-term close friend with daily or near-daily contact. Administer the 16-item interview asking the informant to compare the patient's current performance on 16 specific cognitive and functional tasks to their performance 10 years ago. The 16 items cover everyday memory and practical cognition: remembering recent events, recalling conversations, finding their way around familiar areas, recognizing faces of familiar people, remembering what day/month/year it is, handling financial matters, understanding newspaper/TV programs, making decisions on everyday matters, remembering things from the past, and managing basic household tasks.
Each of the 16 items is rated on a 5-point scale: 1 = Much improved compared to 10 years ago; 2 = A bit improved; 3 = Not much change; 4 = A bit worse; 5 = Much worse. After completing all 16 ratings, calculate the IQCODE-16 mean score = sum of all 16 item scores divided by 16. Range: 1.0 (all much improved) to 5.0 (all much worse). The anchoring to 10 years ago controls for education, premorbid intelligence, and language effects that can confound direct cognitive performance tests. Items rated 1-2 reflect improved or stable function (normal or better); items rated 4-5 reflect decline (clinically relevant). A mean score near 3.0 indicates no significant change; a mean score of 3.3 or above is the most commonly used clinical threshold for significant cognitive decline.
IQCODE-16 mean score interpretation: Below 3.3 = No significant cognitive decline signal from informant perspective — does not exclude MCI or early dementia, but informant has not observed significant change. 3.3 or above = Significant cognitive decline signal — trigger comprehensive cognitive and functional assessment, consider dementia workup (labs, neuroimaging, formal neuropsychological testing). 3.6 or above = Probable clinically significant decline — high suspicion for dementia; formal assessment strongly indicated. When IQCODE-16 exceeds 3.3 but patient MMSE is normal (above 24) or MoCA is borderline, the discordance has diagnostic significance — informant-observed functional decline may precede detectable performance-based cognitive impairment. IQCODE-16 complements rather than replaces direct cognitive testing.
Geriatricians, neurologists, primary care physicians, memory clinic teams
IQCODE is most valuable when direct cognitive performance testing (MMSE, MoCA) may be unreliable due to: low educational attainment (MMSE/MoCA penalize patients with limited formal education), non-native language (performance may reflect language fluency rather than cognition), sensory impairments (hearing or vision impairment affecting test performance), cultural or normative differences, or fatigue and cooperation issues. IQCODE-16 provides an education- and language-independent cognitive decline signal based on observed changes from the patient's own baseline — a fundamentally different measurement approach that complements performance-based testing.
Hospital geriatricians, consultation-liaison teams, delirium prevention programs
In hospitalized patients where baseline cognitive status is unknown, IQCODE-16 provides rapid assessment of pre-morbid cognitive trajectory. A high IQCODE score (mean 3.6 or above) before acute illness indicates the patient had significant pre-existing cognitive decline — establishing the baseline needed to identify superimposed delirium and plan post-discharge cognitive monitoring. IQCODE is particularly useful in emergency department settings where a patient is admitted with delirium and the baseline cognitive status is unknown — a quick informant IQCODE administration clarifies whether delirium is arising in a patient with pre-existing dementia.
General practitioners, primary care physicians, practice nurses, community health teams
IQCODE-16 can be completed by a family member in a waiting room before a clinic appointment, making it a practical pre-consultation screening tool. When a family member accompanies a patient for a consultation, asking them to complete IQCODE-16 while the patient waits provides rapid, standardized informant data without requiring additional appointment time. IQCODE mean of 3.3 or above alerts the GP to initiate a formal cognitive assessment in that or a follow-up appointment. This workflow is used in memory screening programs in the UK, Australia, and Canada.
Nursing home physicians, MDS coordinators, nursing home nurses
IQCODE-16 at nursing home admission provides a validated informant-based cognitive decline history that complements BIMS (direct cognitive testing). Many nursing home admissions occur during delirium or acute medical deterioration when BIMS results may underestimate baseline cognitive function. A family member completing IQCODE-16 at admission documents the pre-admission cognitive trajectory — essential for distinguishing acute-on-chronic cognitive impairment from baseline. IQCODE-16 score at admission is documented in the medical record and informs the care plan baseline.
Epidemiologists, public health researchers, dementia prevalence study investigators
IQCODE has been one of the most widely used informant-based tools in dementia epidemiology research because it is easy to administer by non-specialist interviewers, provides reliable cognitive decline detection across educational and cultural backgrounds, and can be administered by telephone or mail for large-scale studies. IQCODE cross-cultural adaptation has been validated in more than 20 countries across diverse educational and linguistic backgrounds. In population studies where direct cognitive testing is not feasible (telephone surveys, large household surveys), IQCODE provides validated cognitive decline screening for prevalence estimation.
Anesthesiologists, surgical teams, geriatric perioperative medicine teams
Pre-operative cognitive assessment is increasingly recognized as essential for surgical risk stratification in older adults. Post-operative cognitive dysfunction (POCD) and post-operative delirium are more common in patients with pre-existing cognitive impairment. IQCODE-16 administered pre-operatively (typically completed by a family member) provides a rapid pre-morbid cognitive baseline. IQCODE mean of 3.3 or above pre-operatively is a risk factor for post-operative delirium and POCD — informing anesthetic technique choices, ICU monitoring decisions, and post-operative delirium prevention protocols.
IQCODE quality depends entirely on informant quality. The ideal informant has known the patient for 10 or more years (providing an accurate 10-year baseline), has daily or near-daily contact with the patient (observing current cognitive function), and is cognitively intact themselves (to provide reliable recall). A spouse with 30 years of daily observation provides the most reliable IQCODE. An adult child who visits monthly provides less reliable data for daily cognitive task items. Document informant relationship and contact frequency alongside the IQCODE score.
The IQCODE anchors to 10 years ago — not to last year or when the patient 'started having problems.' This 10-year window is specifically designed to capture the full trajectory of age-related versus pathological cognitive change. When informants spontaneously anchor to a more recent time point ('she's been much worse in the last 2 years'), gently redirect: 'For this questionnaire, please compare to how she was 10 years ago, before any memory problems began.' This maintains the standardized reference frame essential for valid IQCODE scoring.
One of the advantages of IQCODE is that informants respond based on observed behavioral change without needing any knowledge of dementia, memory disorders, or cognitive testing. Avoid framing IQCODE items in diagnostic language ('does she have memory problems?'). Use the neutral framing: 'Compared to 10 years ago, how does she do at remembering recent events?' This observational approach reduces rater bias from informant awareness of diagnosis and maintains the behavioral observation focus that validates IQCODE across educational and cultural backgrounds.
The 3.3 cutoff is derived from validation studies with imperfect sensitivity and specificity (~80% each). IQCODE scores of 3.1-3.5 are in the borderline range where clinical context matters most. A borderline IQCODE combined with normal MMSE and no functional concerns may indicate normal aging or mild subjective decline. A borderline IQCODE with abnormal MMSE or functional concerns supports dementia workup. When IQCODE is borderline, repeat in 6-12 months — progressive increase is more meaningful than a single borderline score.
Caregiver or informant depression is a known source of IQCODE inflation. Depressed informants rate more items as 'worse' due to a generally negative cognitive bias in their assessments. If the informant shows signs of depression or appears emotionally overwhelmed, note this and consider whether informant mood may be inflating IQCODE scores. In research settings, concurrent assessment of informant depression (GDS-15 or PHQ-9 for the informant) helps interpret IQCODE scores from potentially biased informants.
The combination of IQCODE-16 and a direct cognitive test (MMSE or MoCA) provides significantly better dementia detection accuracy than either tool alone. A high IQCODE-16 (mean 3.3 or above) combined with impaired MMSE (24 or below) or MoCA (26 or below) provides strong evidence for dementia evaluation. IQCODE-16 high with normal MMSE suggests early functional decline preceding cognitive performance impairment — higher suspicion for early dementia despite normal testing. IQCODE-16 normal with impaired MMSE suggests educational, linguistic, or other non-dementia factors affecting test performance.
The 16-item IQCODE performs similarly to the original long form in validation studies, and common screening thresholds cluster around mean 3.3-3.6 depending on setting.
Higher IQCODE means indicate greater informant-reported cognitive decline and support further structured dementia workup.
Use when a reliable informant is available and longitudinal decline is the key question in cognitive screening.
Results depend on informant reliability and recall, and may be influenced by mood, stress, and observer bias.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Classify dementia severity with the Clinical Dementia Rating global stage (0, 0.5, 1, 2, 3).
OpenGeriatricsStage overall cognitive decline with the 7-level Global Deterioration Scale (GDS) from no decline to very severe dementia.
OpenGeriatricsClassify SLUMS cognitive-screen totals (0-30) to support triage for fuller neurocognitive evaluation.
OpenMental HealthInterpret Montreal Cognitive Assessment (MoCA) scores. The leading cognitive screening tool for mild cognitive impairment and dementia.
Open